| Steven B. Ratoff President & Chief Executive Officer  Mr. Ratoff was appointed by NovaDel's Board in July, 2007, to serve as Interim President and CEO and in 2009 and 2011 as Interim Chief Financial Officer. Effective January 1, 2010, the company's Board of Directors appointed Mr. Ratoff President and Chief Executive Officer. He served as Interim Chief Financial Officer until the appointment of Craig Johnson as Chief Financial Officer in June 2010 and again in 2011 upon Mr. Johnson's resignation.. Mr. Ratoff, a private investor, joined our Board in January 2006 and was elected Chairman of the Board in September 2006. Mr. Ratoff has served as a Venture Partner with ProQuest Investments, a health care venture capital firm, and is a member of the Board of Directors of TorreyPines Therapeutics, Inc. He also served as Chairman of the Board and Interim CEO of CIMA Labs, Inc. prior to its sale to Cephalon, Inc., and as Senior VP and CFO of the Pharmaceutical Group at Bristol-Myers Squibb. Mr. Ratoff brings extensive credentials to the Company from his distinguished career in the pharmaceutical and consumer goods industries. Mr. Ratoff received his B.S. in Business Administration from Boston University and an M.B.A. with Distinction from the University of Michigan. Mr. Ratoff is also a retired Certified Public Accountant. |
| David H. Bergstrom, Ph.D. Senior Vice President & Chief Operating Officer Dr. Bergstrom joined NovaDel in December 2006 as Senior Vice President and Chief Operating Officer. Dr. Bergstrom previously served as Senior Vice President and General Manager of the Pharmaceutical Development business of Cardinal Health, Inc. Dr. Bergstrom previously served as Vice President of Pharmaceutical and Chemical Development at Guilford Pharmaceuticals and also served in senior positions in preclinical development and pharmaceutical and analytical development at Hoechst Marion Roussel, Inc. and Hoechst-Roussel Pharmaceuticals, Inc., both predecessor companies of Sanofi-Aventis Pharmaceuticals, Inc. Prior to that, Dr. Bergstrom worked in pharmaceutical development at CIBA-Geigy Pharmaceuticals, Inc. Dr. Bergstrom received his Ph.D. in Pharmaceutics from the University of Utah, Salt Lake City, his M.S. in Pharmaceutical Chemistry from the University of Michigan, Ann Arbor, and his B.S. in Pharmacy from Ferris State University, Big Rapids, Michigan. |